Thomas is the co-founder and CEO of Owkin, a French-American techbio using foundation models in biology and access to the largest federated patients data network to bring first-in-class AI powered diagnostics and molecules to patients. He leads medical research and business intelligence.
Thomas Clozel is a former Assistant Professor of Clinical Onco-Hematology at Hopital Henri Mondor in Paris and former member of Ari Melnick’s lab at the Weill Cornell Medical College. He ensures that patient health is prioritized when developing breakthrough medical technologies, bringing a patient-centric approach to each Owkin project.
